News | Box Bear expands its senior leadership team with two new hires

Reading Time: < 1 minute

Box Bear, the specialist boutique healthcare agency focusing on innovative digital communications, has expanded its senior leadership team with the appointment of Gareth Stranks (pictured right) as creative director and Rob McCarthy (pictured left) as president of Box Bear America. 

Continue reading or listen here:


Jolyon Hennings, MD and founder, said: “Gareth’s appointment allows us to evolve as a creative force, and bringing in Robbie means we can serve our global and US clients even more successfully. Both bring considerable pharma know-how to the leadership team which really strengthens our ability to excite the customer.”

Stranks, former global marketing creative director at Avalere Health (formerly Hive), brings a decade of experience working in healthcare communications to this exciting new role. Having seen success applying his creativity and problem-solving expertise across many global campaigns, his belief in innovation, dedication to placing the audience at the centre of communications, and passion for mentoring and developing his team makes him a perfect fit within Box Bear’s expanding international presence. 

Rob McCarthy, former GM of Advicenne US, brings decades of experience and expertise from working with healthcare businesses. With a successful track record in consulting, support and strategy development, his charismatic approach to bringing assets to commercial success, has earned him an esteemed reputation.  

Founded by Jolyon Hennings in 2002, Box Bear is an award-winning, independent, evolving media agency with innovation at the heart of all their media solutions. With a world-class R+D pipeline, and a nose-to-tail approach to project delivery, Box Bear leads the healthcare communications industry with creative and imaginative solutions that excite the customer and drive change in behaviour. Based in Crowthorne, UK, current pharmaceutical clients include AstraZeneca, Daiichi Sankyo, GSK, Haleon, Jazz Pharmaceuticals and Viatris.